» Articles » PMID: 24681702

A Risk Factor Analysis of Prospective Symptomatic Haemorrhage in Adult Patients with Cerebral Cavernous Malformation

Overview
Date 2014 Apr 1
PMID 24681702
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to assess the risk factors of prospective symptomatic haemorrhage in a large series of adult patients with cerebral cavernous malformation (CM).

Methods: Three hundred twenty-six patients >18 years of age with 410 CMs were evaluated retrospectively. Symptomatic haemorrhage was defined as new clinical symptoms with radiographic features of haemorrhage. Clinical data and the characteristics of CM were analysed. MR appearance was divided into three groups according to Zabramski's classification.

Results: The overall haemorrhage rate of CM was 4.46% per lesion-year. The overall annual haemorrhage rate according to MR appearance was as follows: type I, 9.47%; type II, 4.74%; and type III, 1.43%. A multivariate analysis revealed that prior symptomatic haemorrhage (p<0.001) and MR appearance (p<0.001) were statistically significant. After multiple comparisons, type I (p<0.001) and type II (p=0.016) showed higher haemorrhage risk than type III. However, no significant difference in haemorrhage rate was observed between type I and type II (p=0.105). Other variables including female gender, age, location, multiplicity, hypertension, size and associated venous angioma were not significant. The haemorrhage rates based on risk factors were estimated at 3 years as follows: 33.77% in patients with prior haemorrhage versus 7.54% in patients without prior haemorrhage (p<0.001); type I, 27.62% vs type II, 15.44% vs type III, 5.38% (p<0.001).

Conclusions: Prior symptomatic haemorrhage and MR appearance could be related to prospective symptomatic CM haemorrhage in adults. A prospective multicentre observational study is necessary to confirm our results.

Citing Articles

Outcomes after surgical and nonsurgical treatment of pediatric cerebral cavernous malformation.

Zhang H, Yu Q, Mao Z, Zhang L, Yu X Pediatr Investig. 2024; 8(2):126-134.

PMID: 38910851 PMC: 11193375. DOI: 10.1002/ped4.12435.


Identifying potential (re)hemorrhage among sporadic cerebral cavernous malformations using machine learning.

Li X, Jones P, Zhao M Sci Rep. 2024; 14(1):11022.

PMID: 38745042 PMC: 11094099. DOI: 10.1038/s41598-024-61851-4.


Association of hemorrhage-to-treatment time with outcomes in patients with brainstem cavernous malformations: a nationwide cohort study.

Li Z, Lu J, Liu M, Ma L, Quan K, Zhang H Int J Surg. 2024; 110(4):2217-2225.

PMID: 38668661 PMC: 11020047. DOI: 10.1097/JS9.0000000000001111.


The effect of different brain lesions on the reorganization of language functions within the dominant hemisphere assessed with task-based BOLD-fMRI.

Piccirilli E, Sestieri C, Di Clemente L, Delli Pizzi A, Colasurdo M, Panara V Radiol Med. 2023; 128(6):775-783.

PMID: 37184809 DOI: 10.1007/s11547-023-01642-5.


Effects of medication intake on the risk of hemorrhage in patients with sporadic cerebral cavernous malformations.

Chen B, Lahl K, Saban D, Lenkeit A, Rauschenbach L, Santos A Front Neurol. 2023; 13:1010170.

PMID: 36686509 PMC: 9847255. DOI: 10.3389/fneur.2022.1010170.